News
Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative ...
The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback